Blueprint Medicines
Earnings Date & Report
Last updated:
Blueprint Medicines’s last earnings date was on 2 May 2024.
Blueprint Medicines stock Earnings report, Estimates & History
| 2019-11-05 | -2.18 | -1.93 |
|---|---|---|
| 2020-02-13 | -1.69 | -1.35 |
| 2020-05-06 | -2.08 | -2.11 |
| 2020-07-30 | -2.14 | -2.28 |
| 2020-10-29 | 7.72 | 11.16 |
| 2021-02-17 | -1.62 | -1.53 |
| 2021-04-29 | -1.87 | -1.72 |
| 2021-07-29 | -1.86 | -1.86 |
| 2021-10-28 | -1.63 | -1.94 |
| 2022-02-16 | -1.65 | -5.4 |
| 2022-05-03 | -1.86 | -1.79 |
| 2022-08-02 | -2.23 | -2.68 |
| 2022-11-01 | -2.49 | -2.23 |
| 2023-02-16 | -2.65 | -2.65 |
| 2023-05-04 | -2.67 | -2.15 |
| 2023-08-02 | -2.55 | -2.68 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Blueprint Medicines stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 2 May 2024 | N/A | N/A | N/A | N/A | N/A | Earnings Call Transcript |
| 14 Feb 2024 | N/A | N/A | N/A | N/A | N/A | Earnings Call Transcript |
| 30 Oct 2023 | N/A | N/A | N/A | N/A | N/A | |
| 2 Aug 2023 | Missed | -$2.55 | -$2.68 | 44.8M | N/A | Earnings Call Transcript |
| 4 May 2023 | Beat | -$2.67 | -$2.15 | 41.96M | 63.28M | Earnings Call Transcript |
| 16 Feb 2023 | Matched | -$2.65 | -$2.65 | 43.37M | 38.78M | Earnings Call Transcript |
| 31 Dec 2022 | N/A | N/A | -$2.65 | N/A | 38.78M | |
| 1 Nov 2022 | Beat | -$2.49 | -$2.23 | N/A | 65.97M | |
| 2 Aug 2022 | Missed | -$2.23 | -$2.68 | N/A | 36.54M | Earnings Call Transcript |
| 3 May 2022 | Beat | -$1.86 | -$1.79 | 65.09M | 62.73M | Earnings Call Transcript |
| 16 Feb 2022 | Missed | -$1.65 | -$5.4 | 99.4M | 107.02M | Earnings Call Transcript |
| 28 Oct 2021 | Missed | -$1.63 | -$1.94 | 44.17M | 24.18M | Earnings Call Transcript |
| 29 Jul 2021 | Matched | -$1.86 | -$1.86 | 27.29M | 27.29M | Earnings Call Transcript |
| 29 Apr 2021 | Beat | -$1.87 | -$1.72 | 22.91M | 21.57M | Earnings Call Transcript |
| 17 Feb 2021 | Beat | -$1.62 | -$1.53 | 29.24M | 34.10M | Earnings Call Transcript |
| 29 Oct 2020 | Beat | $7.72 | $11.16 | 515.44M | 745.11M | Earnings Call Transcript |
| 30 Jul 2020 | Missed | -$2.14 | -$2.28 | 7.83M | 8.34M | Earnings Call Transcript |
| 6 May 2020 | Missed | -$2.08 | -$2.11 | 6.07M | 6.16M | Earnings Call Transcript |
| 13 Feb 2020 | Beat | -$1.69 | -$1.35 | 64.51M | 51.53M | Earnings Call Transcript |
| 5 Nov 2019 | Beat | -$2.18 | -$1.93 | 10.32M | 9.13M | |
Blueprint Medicines Earnings report FAQs
When is Blueprint Medicines's next Earnings date?
The company has not set the next earnings date yet. The latest Blueprint Medicines's earnings date was on 4 May 2023.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.